FLXN

Flexion Therapeutics Inc.

Price

$25.67

return (12m)

0.00%

p/e

-12.40

p/bv

-15.16

DIVIDEND YIELD

8.39%

FLXN price

Flexion Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment FLXN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals FLXN

Valuation

P/E

-12.40

Sector -4.15

Industry -4.15

P/BV

-15.16

Sector 2.06

Industry 2.06

P/Revenue (PSR)

12.44

Sector -4.16

Industry -4.16

EV/EBITDA

-57.64

Sector -241.86

Industry -241.86

EV/EBIT

-55.34

Sector -671.75

Industry -671.75

P/EBITDA

-16.50

Sector -4.30

Industry -4.30

P/EBIT

-15.73

Sector -4.35

Industry -4.35

P/Total Assets

5.73

Sector 1.46

Industry 1.46

P/Net Current Assets

-11.61

Sector -12.67

Industry -12.67

P/Working Capital

8.40

Sector -12.58

Industry -12.58

EPS

-2.01

Sector -2.19

Industry -2.19

BVPS

-1.65

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

78.93%

Sector 36.44%

Industry 36.44%

EBITDA Margin

-110.41%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

-115.00%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

-78.16%

Sector -38.78%

Industry -38.78%

Net Profit Margins

-100.00%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.10

Sector 0.03

Industry 0.03

Profitability

ROE

122.27%

Sector -67.01%

Industry -67.01%

ROA

-46.22%

Sector -66.28%

Industry -66.28%

ROIC

-180.79%

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

8.39%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.38

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-4.61

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

-4.42

Sector -3.79

Industry -3.79

Net Debt / Equity

-1.32

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

-3.04

Sector 0.00

Industry 0.00

Equity/Assets

-0.38

Sector 0.42

Industry 0.42

Liabilities/Assets

1.38

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

6.27%

Sector -

Industry -

5Y Earnings CAGR

4.44%

Sector -

Industry -

Fundamentals FLXN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
FLXN Flexion Therapeutics Inc.	$25.67	-	8.39%	-12.40	-15.16	122.27%	-100.00%
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

FLXN Historical Dividends

current DY: 8.39%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/27/2026	03/02/2026	0.11490000
Dividends	12/24/2025	12/26/2025	0.73900000
Dividends	08/22/2025	08/25/2025	0.14580000

ABOUT Flexion Therapeutics

Flexion Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

19 years

Founded: 2007

2014

Time since IPO - 12 years

257

Employees

Flexion Therapeutics Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $1.25 billion, with shareholders equity totaling $-82.38 million.

The company employs approximately 257 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, Flexion Therapeutics Inc. reported $100.41 million in revenue, generating net income of $-100.73 million.

Key financial metrics include a P/E ratio of -12.40, a price-to-book (P/B) ratio of -15.16, and a trailing twelve-month dividend yield of 8.39%.

The company trades under the ticker FLXN.

Market cap

$1.25 billion

Net worth

$-82.38 million

$-82,380,000.00

Assets

$217.93 million

$217,930,000.00

Total Shares Outstanding

50.00 million

50,000,000

Average Daily Trading Volume

$12.48 Thousand

$12,483.20

Sector

Healthcare

Industry

Biotecnologia

FLXN

FLXN revenue and profits

Financial Results FLXN

DRAG THE FRAME TO SEE MORE DATA

FLXN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$204.64 40,78% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14